Alzamend Accounts Payable from 2010 to 2025
| ALZN Stock | USD 1.27 0.01 0.79% |
Accounts Payable | First Reported 2010-12-31 | Previous Quarter 3.4 M | Current Value 3.5 M | Quarterly Volatility 1.3 M |
Check Alzamend Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alzamend Neuro's main balance sheet or income statement drivers, such as Interest Expense of 11 K, Interest Income of 0.0 or Depreciation And Amortization of 43.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Alzamend financial statements analysis is a perfect complement when working with Alzamend Neuro Valuation or Volatility modules.
Alzamend | Accounts Payable |
Latest Alzamend Neuro's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Alzamend Neuro over the last few years. An accounting item on the balance sheet that represents Alzamend Neuro obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Alzamend Neuro are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Alzamend Neuro's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alzamend Neuro's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
Alzamend Accounts Payable Regression Statistics
| Arithmetic Mean | 1,085,225 | |
| Geometric Mean | 448,904 | |
| Coefficient Of Variation | 120.26 | |
| Mean Deviation | 1,055,897 | |
| Median | 503,591 | |
| Standard Deviation | 1,305,119 | |
| Sample Variance | 1.7T | |
| Range | 3.4M | |
| R-Value | 0.86 | |
| Mean Square Error | 459.5B | |
| R-Squared | 0.75 | |
| Significance | 0.000015 | |
| Slope | 237,121 | |
| Total Sum of Squares | 25.6T |
Alzamend Accounts Payable History
About Alzamend Neuro Financial Statements
Alzamend Neuro investors utilize fundamental indicators, such as Accounts Payable, to predict how Alzamend Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 3.4 M | 3.5 M |
Check out the analysis of Alzamend Neuro Correlation against competitors. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.